These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8399290)

  • 1. Structural requirements for the inhibition of membrane fusion by carbobenzoxy-D-Phe-Phe-Gly.
    Epand RM; Epand RF; Richardson CD; Yeagle PL
    Biochim Biophys Acta; 1993 Oct; 1152(1):128-34. PubMed ID: 8399290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of carbobenzoxy-D-phenylalanine-L-phenylalanine-glycine, an inhibitor of membrane fusion, in phospholipid bilayers with multinuclear magnetic resonance.
    Dentino AR; Westerman PW; Yeagle PL
    Biochim Biophys Acta; 1995 May; 1235(2):213-20. PubMed ID: 7756328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the mechanism of inhibition of viral and vesicle membrane fusion by carbobenzoxy-D-phenylalanyl-L-phenylalanylglycine.
    Yeagle PL; Young J; Hui SW; Epand RM
    Biochemistry; 1992 Mar; 31(12):3177-83. PubMed ID: 1554703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of lipid polymorphism by the feline leukemia virus fusion peptide: implications for the fusion mechanism.
    Davies SM; Epand RF; Bradshaw JP; Epand RM
    Biochemistry; 1998 Apr; 37(16):5720-9. PubMed ID: 9548958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between the infectivity of influenza virus and the ability of its fusion peptide to perturb bilayers.
    Epand RM; Epand RF
    Biochem Biophys Res Commun; 1994 Aug; 202(3):1420-5. PubMed ID: 8060322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virus replication inhibitory peptide inhibits the conversion of phospholipid bilayers to the hexagonal phase.
    Epand RM
    Biosci Rep; 1986 Jul; 6(7):647-53. PubMed ID: 3779040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton induced vesicle fusion and the isothermal lalpha-->HII phase transition of lipid bilayers: a 31P-NMR and titration calorimetry study.
    Wenk MR; Seelig J
    Biochim Biophys Acta; 1998 Jul; 1372(2):227-36. PubMed ID: 9675291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane orientation of the SIV fusion peptide determines its effect on bilayer stability and ability to promote membrane fusion.
    Epand RF; Martin I; Ruysschaert JM; Epand RM
    Biochem Biophys Res Commun; 1994 Dec; 205(3):1938-43. PubMed ID: 7811285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and orientation study of Ebola fusion peptide inserted in lipid membrane models.
    Agopian A; Castano S
    Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):117-26. PubMed ID: 24055820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of fusion inhibitors on the phase behaviour of N-methylated dioleoylphosphatidylethanolamine.
    Darkes MJ; Harroun TA; Davies SM; Bradshaw JP
    Biochim Biophys Acta; 2002 Mar; 1561(1):119-28. PubMed ID: 11988186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptides as potential virus inhibitors. Synthesis and bioassay of five respiratory syncytial virus peptide analogs with antimeasles activity.
    Lobl TJ; Renis HE; Epand RM; Maggiora LL; Wathen MW
    Int J Pept Protein Res; 1988 Nov; 32(5):326-30. PubMed ID: 2850279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrophobic lipid additives affect membrane stability and phase behavior of N-monomethyldioleoylphosphatidylethanolamine.
    van Gorkom LC; Nie SQ; Epand RM
    Biochemistry; 1992 Jan; 31(3):671-7. PubMed ID: 1731922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of lipid molecule headgroup mismatch on non steroidal anti-inflammatory drugs induced membrane fusion.
    Mondal Roy S; Sarkar M
    Langmuir; 2011 Dec; 27(24):15054-64. PubMed ID: 21999838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilayer stabilizing peptides and the inhibition of viral infection: antimeasles activity of carbobenzoxy-Ser-Leu-amide.
    Epand RM; Lobl TJ; Renis HE
    Biosci Rep; 1987 Sep; 7(9):745-9. PubMed ID: 3427222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Sendai virus fusion with phospholipid vesicles and human erythrocyte membranes by hydrophobic peptides.
    Kelsey DR; Flanagan TD; Young JE; Yeagle PL
    Virology; 1991 Jun; 182(2):690-702. PubMed ID: 1850923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of liposome destabilization by polycationic amino acids.
    Epand RM; Lim W
    Biosci Rep; 1995 Jun; 15(3):151-60. PubMed ID: 7579040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermodynamics of interaction of the fusion-inhibiting peptide Z-D-Phe-L-Phe-Gly with dioleoylphosphatidylcholine vesicles: direct calorimetric determination.
    Turner DC; Straume M; Kasimova MR; Gaber BP
    Biochemistry; 1995 Jul; 34(29):9517-25. PubMed ID: 7626621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of viral chemotherapeutic agents on membrane properties. Studies of cyclosporin A, benzyloxycarbonyl-D-Phe-L-Phe-Gly and amantadine.
    Epand RM; Epand RF; McKenzie RC
    J Biol Chem; 1987 Feb; 262(4):1526-9. PubMed ID: 2433282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of a peptide model of a hydrophobic transmembrane alpha-helical segment of a membrane protein with phosphatidylethanolamine bilayers: differential scanning calorimetric and Fourier transform infrared spectroscopic studies.
    Zhang YP; Lewis RN; Hodges RS; McElhaney RN
    Biophys J; 1995 Mar; 68(3):847-57. PubMed ID: 7756552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide inhibitors of enveloped virus infection inhibit phospholipid vesicle fusion and Sendai virus fusion with phospholipid vesicles.
    Kelsey DR; Flanagan TD; Young J; Yeagle PL
    J Biol Chem; 1990 Jul; 265(21):12178-83. PubMed ID: 2165053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.